156 related articles for article (PubMed ID: 34591803)
1. A Case of Aseptic Meningitis Without Skin Rash Caused by Oka Varicella Vaccine.
Kawamura Y; Suzuki D; Kono T; Miura H; Kozawa K; Mizuno H; Yoshikawa T
Pediatr Infect Dis J; 2022 Jan; 41(1):78-79. PubMed ID: 34591803
[TBL] [Abstract][Full Text] [Related]
2. Safety of a second dose of varicella vaccine administered at 4 to 6 years of age in healthy children in Argentina.
Fridman D; Monti A; Bonnet MC; Armoni J; Stamboulian D
Hum Vaccin; 2011 Oct; 7(10):1066-71. PubMed ID: 21989288
[TBL] [Abstract][Full Text] [Related]
3. Case report: aseptic meningitis secondary to varicella-zoster virus (VZV) without an exanthem post MMR vaccination.
Sahra S; Jahangir A; Glaser A; Mobarakai N; Jahangir A
BMC Infect Dis; 2021 Aug; 21(1):746. PubMed ID: 34344345
[TBL] [Abstract][Full Text] [Related]
4. Vaccine-Strain Varicella Virus Transmitted to a Term Infant Following Maternal Postpartum Vaccination.
Saringkarisate K; Len KA; Melish ME; Prothero BK; Ching N
J Pediatric Infect Dis Soc; 2022 Oct; 11(10):452-453. PubMed ID: 35751631
[TBL] [Abstract][Full Text] [Related]
5. Safety and immunogenicity of single dose live attenuated varicella vaccine (VR 795 Oka strain) in healthy Indian children: a randomized controlled study.
Mitra M; Faridi M; Ghosh A; Shah N; Shah R; Chaterjee S; Narang M; Bhattacharya N; Bhat G; Choudhury H; Kadhe G; Mane A; Roy S
Hum Vaccin Immunother; 2015; 11(2):443-9. PubMed ID: 25692656
[TBL] [Abstract][Full Text] [Related]
6. Safety of Second-Dose Single-Antigen Varicella Vaccine.
Su JR; Leroy Z; Lewis PW; Haber P; Marin M; Leung J; Woo EJ; Shimabukuro TT
Pediatrics; 2017 Mar; 139(3):. PubMed ID: 28174201
[TBL] [Abstract][Full Text] [Related]
7. Flexibility in the administration schedule of varicella vaccination in healthy adolescents and young adults.
Kosuwon P; Wasi C; Sutra S; Kositanont U; Hutagalung Y; Bock HL
Asian Pac J Allergy Immunol; 2002 Dec; 20(4):241-5. PubMed ID: 12744625
[TBL] [Abstract][Full Text] [Related]
8. Experience with live attenuated varicella vaccine (Oka strain) in healthy Japanese subjects; 10-year survey at pediatric clinic.
Ozaki T; Nishimura N; Kajita Y
Vaccine; 2000 May; 18(22):2375-80. PubMed ID: 10738094
[TBL] [Abstract][Full Text] [Related]
9. Safety profile of the varicella vaccine (Oka vaccine strain) based on reported cases from 2005 to 2015 in Japan.
Yoshikawa T; Ando Y; Nakagawa T; Gomi Y
Vaccine; 2016 Sep; 34(41):4943-4947. PubMed ID: 27591104
[TBL] [Abstract][Full Text] [Related]
10. Long-term clinical studies of varicella vaccine at a regional hospital in Japan and proposal for a varicella vaccination program.
Ozaki T
Vaccine; 2013 Dec; 31(51):6155-60. PubMed ID: 24183712
[TBL] [Abstract][Full Text] [Related]
11. Serious neurological adverse events in immunocompetent children and adolescents caused by viral reactivation in the years following varicella vaccination.
Ramachandran P; Grose C
Rev Med Virol; 2024 May; 34(3):e2538. PubMed ID: 38658176
[TBL] [Abstract][Full Text] [Related]
12. 25 years' experience with the Biken Oka strain varicella vaccine: a clinical overview.
Takahashi M
Paediatr Drugs; 2001; 3(4):285-92. PubMed ID: 11354700
[TBL] [Abstract][Full Text] [Related]
13. Effectiveness of the Oka/GSK attenuated varicella vaccine for the prevention of chickenpox in clinical practice in Israel.
Sheffer R; Segal D; Rahamani S; Dalal I; Linhart Y; Stein M; Shohat T; Somekh E
Pediatr Infect Dis J; 2005 May; 24(5):434-7. PubMed ID: 15876943
[TBL] [Abstract][Full Text] [Related]
14. Varicella Zoster Reactivation Causing Aseptic Meningitis in Healthy Adolescents: A Case Series And Review Of The Literature.
Barry R; Prentice M; Costello D; O'Mahony O; DeGascun C; Felsenstein S
Pediatr Infect Dis J; 2020 Sep; 39(9):e278-e282. PubMed ID: 32467453
[TBL] [Abstract][Full Text] [Related]
15. Chickenpox vaccines: new drugs. A favourable risk-benefit balance in some situations.
Prescrire Int; 2005 Jun; 14(77):85-91. PubMed ID: 15977369
[TBL] [Abstract][Full Text] [Related]
16. Vaccine Oka Varicella Meningitis in Two Adolescents.
Harrington WE; Mató S; Burroughs L; Carpenter PA; Gershon A; Schmid DS; Englund JA
Pediatrics; 2019 Dec; 144(6):. PubMed ID: 31776194
[TBL] [Abstract][Full Text] [Related]
17. Varicella infection caused by Oka strain vaccine in a heart transplant recipient.
Kraft JN; Shaw JC
Arch Dermatol; 2006 Jul; 142(7):943-5. PubMed ID: 16847227
[No Abstract] [Full Text] [Related]
18. Varicella zoster virus vaccines: potential complications and possible improvements.
Silver B; Zhu H
Virol Sin; 2014 Oct; 29(5):265-73. PubMed ID: 25358998
[TBL] [Abstract][Full Text] [Related]
19. A dose-response study of a live attenuated varicella-zoster virus (Oka strain) vaccine administered to adults 55 years of age and older.
Berger R; Trannoy E; Holländer G; Bailleux F; Rudin C; Creusvaux H
J Infect Dis; 1998 Nov; 178 Suppl 1():S99-103. PubMed ID: 9852985
[TBL] [Abstract][Full Text] [Related]
20. Varicella Vaccine-Induced Infantile Zoster-Like Skin Rash.
Sugai T; Fujita Y; Yamada S; Fukushi S; Inamura E; Hatakeyama K; Shimizu S
J Pediatr; 2022 Dec; 251():218-219. PubMed ID: 36027973
[No Abstract] [Full Text] [Related]
[Next] [New Search]
